Trade Summary

Yesterday, Goncalves Joana, serving as Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,947 shares at $69.28 per share, for a total transaction value of $550,606.92. Following this transaction, Goncalves Joana now holds 32,718 shares of ORKA.

This sale represents a 19.54% decrease in Goncalves Joana's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 15, 2026 at 6:54 PM ET, meaning the disclosure happened on the same day as the trade.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.